Home / Natalizumab / Czechia
CZ ATC L04AG03 · updated 2 Nov 2026
Natalizumab shortage in Czechia
Is there a Natalizumab shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Natalizumab product is reported short in Czechia, the first since 29 Oct 2026. The company estimate for the return is 15 Jan 2027. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | TYRUKO 300MG 300MG INF CNC SOL 1X15ML | Sandoz GmbH, Kundl | 29 Oct 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.